Safety of Active Surveillance Program for Recurrent Nonmuscle-invasive Bladder Carcinoma

Urology

Volumn 73, Issue 6, 2009, Pages 1306-1310

  Hernandez V ^a   Alvarez, M ^a   Peña, E de la ^a   Amaruch, N ^a   Martin M D ^a   de la Morena, J M ^a   Gomez V ^a   Llorente, C ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INVASION; CANCER RISK; CARCINOMA IN SITU; COHORT ANALYSIS; CONTROLLED STUDY; CYTOLOGY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; PAPILLOMA; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRANSURETHRAL RESECTION;

AGED; CARCINOMA, PAPILLARY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SAFETY; URINARY BLADDER NEOPLASMS;

EID: 67349167641     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.12.061     Document Type: Article

References (17)

1. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., et al. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 164 (2000) 680-684
2. Herr H.W. Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors. J Urol 144 (1990) 1365-1366
3. Sylvester R.J., van der Meijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006) 466-465, 475-477.
4. Soloway M.S., Bruck D.S., and Kim S.S. Expectant management of small, recurrent, noninvasive papillary bladder tumors. J Urol 170 (2003) 438-441
5. Gofrit O.N., Pode D., Lazar A., et al. Watchful waiting policy in recurrent TaG1 bladder tumors. Eur Urol 49 (2006) 303-307
6. Prout Jr. G.R., Barton B.A., Griffin P.P., et al., National Bladder Cancer Group. Treated history of noninvasive grade 1 transitional cell carcinoma. J Urol 148 (1992) 1413-1419
7. Collado A., Chechile G.E., Salvador J., et al. Early complications of endoscopic treatment for superficial bladder tumors. J Urol 164 (2000) 1529-1532
8. Herr H.W. Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?. BJU Int 88 (2001) 683-685
9. Satoh E., Miyao N., Tachiki H., et al. Prediction of muscle invasion of bladder cancer by cystoscopy. Eur Urol 41 (2002) 178-181
10. Donat S.M., North A., Dalbagni G., et al. Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm. J Urol 171 (2004) 636-639
11. Hasui Y., Osada Y., Kitada S., et al. Significance of invasion to the muscularis mucosa on the progression of superficial bladder cancer. Urology 43 (1994) 782-786
12. Martinez Caceres P., Hidalgo Arroyo J.G., and Chechile Toniolo G.E. Is it necessary to always treat the relapses of superficial bladder tumour at the moment of diagnosis?. Preliminary communication. Actas Urol Esp 29 (2005) 567-571
13. Pruthi R.S., Baldwin N., Bhalani V., et al. Conservative management of low risk superficial bladder tumors. J Urol 179 (2008) 87-90
14. Soloway M.S. Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder. Urol Oncol 24 (2006) 58-61
15. Burke D.M., Shackley D.C., and O'Reilly P.H. The community-based morbidity of flexible cystoscopy. BJU Int 89 (2002) 347-349
16. Babjuk M., Oosterlinck W., Sylvester R., et al. EAU guidelines on nonmuscle-invasive urothelial carcinoma of the bladder. Eur Urol 54 (2008) 303-314
17. Brown F.M. Urine cytology: it is still the gold standard for screening?. Urol Clin North Am 27 (2000) 25-37